Loan & DebtNov 12, 2026, 04:38 PM
Trinity Biotech PLC Amends Credit Agreement, Waives Liquidity Covenant
AI Summary
Trinity Biotech PLC announced a Limited Waiver and Fifth Amendment to its Sixth Amended and Restated Credit Agreement and Guaranty. The amendment waives compliance with the Minimum Liquidity Covenant for the period from June 2026 through October 2026, as the company had not met the required liquidity levels in prior months. Additionally, amendments were made to two Warrant Certificates, adjusting the exercise price per ADS to $5.90 for both.
Key Highlights
- Trinity Biotech PLC and its subsidiaries entered into a Limited Waiver and Fifth Amendment to their Sixth Amended and Restated Credit Agreement and Guaranty.
- The amendment waives compliance with the Minimum Liquidity Covenant for June 2026 through October 2026.
- The company had not been in compliance with the Minimum Liquidity Covenant for June, July, and August 2026.
- The exercise price per ADS under Warrant Certificate No. 1 was amended to $5.90.
- The exercise price per ADS under Warrant Certificate No. 2 was amended to $5.90.
Price Impact
More from TRIB